Collegium taking away Oxy Sales

Discussion in 'Purdue' started by anonymous, Jun 9, 2016 at 9:44 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Our rookie reps are stealing your market!

    You can apply for a job here if you want to try but you will have to work.
     

  2. anonymous

    anonymous Guest

    You know Purdue won't hire you back right?
    "Doc, why would you want OxyContin when you can have this non-formulary version that requires you to eat when you take it? Who doesn't like food? Am I right?"
     
  3. anonymous

    anonymous Guest

    has it been launched? Haven't seen a thing in my territory.
     
  4. anonymous

    anonymous Guest

    Company is saying launch by end of June
     
  5. anonymous

    anonymous Guest

    Hysterical. Not even PURDUE will hire Purdue reps. Talk about the stink of death. Lol...
     
  6. anonymous

    anonymous Guest

    Look at all of the former Purdue people who have been rehired by Purdue - Phil Cramer. HR Head. DM in the South East.

    So apparently PP does rehire people who were at PP and then left.

    Like the Blue Brothers - We're putting the band back together!!!!
     
  7. anonymous

    anonymous Guest


    They have no choice, no one else wants the name Purdue soiling their resume...so, of course, it's a natural fit. No one wants to work at Purdue or hire Purdue reps, so everybody wins! It's like the last two drunks at the bar finding each other at closing time. A match made in heaven. <3
     
  8. anonymous

    anonymous Guest

    Collegium is up to $12M per quarter - impressive
     
  9. anonymous

    anonymous Guest

    GO BACK TO YOUR OWN BOARD PURDUE WANNABEE.

    OXYCONTIN IS A $3 BILLION DOLLAR DRUG AND HAS BEEN #1 ER OPIOD FOR 20 YEARS. MANY HAVE TRIED AND ALL HAVE FAILED. NO PRODUCT WILL EBER COME CLOSE TO OXYCONTIN ESPECIALLY IN THIS CLIMATE WITH THE WARS ON OPIODS.

    GO NOW AND PROMOTE YOUR LITTLE DRUG. YOU ARE NOT EBEN PUTTING A DENT IN OUR SALES.
     
  10. anonymous

    anonymous Guest





    Check the balance sheets! OP is no longer a 3B drug and is losing market share and dollar volume daily. That little drug you speak of is slowly taking away millions and you people are too stupid to even know it because Purdue quit showing you the real data long long ago! It’s almost over Purduezies! The imminent layoffs will leave you a shell of what you once were! The fat lady is about to sing!
     
  11. anonymous

    anonymous Guest

     
  12. anonymous

    anonymous Guest


    OK BABY DRUG! LOL!! OXYCONTIN IS AND HAS SLESYS BEEN THE GOAL STANDARD FOR ANYNEW OPIOD, IF IT WASNT, YOU WOULDNT BE ON THIS BOARD BRAGGING ABOUT YOUR DOUBLE DIGIT SCRIPT COUNT PER WEEK! LMAO. BTW, YHE AVERAGE TERRITORY HAS 300-500 SCRIPTS PER WEEK. BITE ON THAT. YOU ARE NOT OUR COMPETITION. WE ARE YOUR MODEL. IT EILL TAKE YOU 20 YEARS FOR YOU TO GET WHERE WE ARE. WE DIBT EVEN DISCUSS YALL. YOU ARE A NON MUTHAF*** FACTOR.
     
  13. anonymous

    anonymous Guest

    Judging by this awful post, spelling and grammar, I would say you are sampling yourself a little too much on the ole oxy. Get a grip my friend.
     
  14. anonymous

    anonymous Guest


    -or it could be the tired keyboard on the old iphone dumbas. Know the difference between grammar and spelling.
     
  15. anonymous

    anonymous Guest





    It’s the return of the “dumbas” speller who can’t spell shit and is a complete idiot! Just ignore him!